HOXA10 and hepatocellular carcinoma: In conclusion, this study identified and internally evaluated a five-gene metabolic signature (PLPPR1, CNTN3, HOXA10, HAGLR, and ENPP3) associated with immunotherapy response in hepatocellular carcinoma through integrative analysis of multiple transcriptomic datasets.